Stay updated on Pembrolizumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check8 days agoChange DetectedThe web page has updated its version from v2.16.2 to v2.16.3 and changed the date from 2024-05-13 to 2025-06-11.SummaryDifference1%
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check23 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check66 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.